Introduction
In part A of our paper (Jongen et al., 2016) we gave an overview of a new cardiotocogram (CTG) simulation model. Compared to our previous model (van der Hout-van der Jagt et al., 2012 , 2013a the complexity of some submodels was reduced and the physical basis for the description of other submodels was enhanced. It was shown that the model was able to simulate realistic FHR decrease in response to uterine flow reduction as induced by uterine contractions.
In this part the model is used to gain insight into the mechanism of variable FHR decelerations which are caused by umbilical cord compressions, that mostly occur during uterine contractions during labor (Freeman et al., 2012) . Variable decelerations are defined as an abrupt FHR decrease of more than 15 bpm, with a maximum time delay of 30 s between onset of the deceleration and FHR nadir, and a duration of less than 2 min (Macones et al., 2008; Robinson, 2008) . In addition, the effect of varying amplitude and duration of uterine contractions on the CTG is investigated. We also compare model output with data of sheep experiments in which the umbilical cord was temporarily blocked by use of an occluder (Itskovitz et al., 1983) . Although model complexity was reduced, parameter estimation is difficult due to the limited clinical data. Therefore, we will extensively describe and discuss estimation of these parameter values.
The new model is intended to be used to gain insight into the regulation of FHR during labor and delivery. For use as a clinical decision support tool, the model should be made patient-specific. This is a challenging task in view of the limited availability of clinical data and the limited time span for model analysis during labor. Use as an educational tool would be a more realistic next step.
Material and methods
The model is extensively described in part A of our study (Jongen et al., 2016) . In part B we extend the model in order to simulate combined uterine blood flow reduction and umbilical cord compression induced by contractions. Besides an overview of model parameter estimation is given.
Model extension
Since during cord compression the umbilical vein and arteries are exposed to large changes in transmural pressure, the corresponding resistances, R umv and R uma respectively, are modeled as function of transmural pressure p tm (part A, Eq. (6)). Parameter values are chosen such that first the umbilical vein will be closed, followed by the umbilical arteries at higher external umbilical pressures, see Table 1 .
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The transmural pressure of the umbilical vein p tm;umv and umbilical arteries p tm;uma is determined as the mean absolute pressure of the two neighboring blood compartments minus the external pressure:
where the external pressure consists of the uterine pressure p ut , that acts on the whole fetus, plus an extra pressure p um , caused by umbilical cord compression. The degree of cord compression depends on the contraction intensity, fetal position, stage of labor, etc. The effect of these random variables is modeled through a weighting factor w um [-] , relating p ut to the external pressure on the umbilical cord p um :
with p rest uterine resting pressure.
Parameter estimation
Due to the limited available human fetal data, parameter estimation is difficult. For this reason parameter estimation is extensively described. Fetal cardiovascular parameters were obtained from literature and set to values of a 3.5 kg full term human fetus. If human data were not available, fetal sheep data were used to derive the parameters. Some parameter values were set to obtain the desired model responses. Parameter choices are briefly explained below, all parameter values can be found in Tables 1-3 of part A.
Feto-maternal hemodynamics
Fetal combined ventricular output q CO was aimed at 450 ml/min/kg (Kiserud et al., 2006; Parer, 1997; Rudolph, 2009; van Mieghem et al., 2009) , ejection fraction EF at 0.67 (Schmidt et al., 1995) , and heart rate at 135 bpm (part A, Table 1a ). Mean arterial transmural blood pressure p tm;a and mean transmural venous blood pressure p tm;v were set to 45 mmHg (Itskovitz et al., 1983; Struijk et al., 2008; Thornburg and Morton, 1986; Unno et al., 1999 ) and 3 mmHg (Johnson et al., 2000; Rudolph, 2009; Thornburg and Morton, 1986) respectively. Fetal blood volume was reported to be about 75 ml/kg (Linderkamp et al., 1978; Usher et al., 1963; Yao et al., 1969) , which is about two third of total feto-placental blood volume (Yao et al., 1969) . Therefore, the latter volume was set to 110 ml/kg, which is in accordance with Schwarz and Galinkin (2003) . Total microcirculation blood volume was computed from Guyton and Hall (2006) and set to 8% of fetal body blood volume, which was distributed over cerebral (14%) (Cetin et al., 2008; Hofman, 1983) and tissue microcirculation (86%). Average cardiac cavity volume follows from q CO , EF and FHR and equals 11.7 ml. The remainder of the body blood volume was distributed over the systemic fetal arteries (1/6) and veins (5/6). Based on geometric considerations (Di Naro et al., 2001; Link et al., 2007; Walker and Pye, 1960) blood volume of the umbilical circulation was divided between the placental villi (65%), umbilical arteries (10%) and vein (25%). Since for the umbilical arteries and vein no separate compartments were included in the model, these blood volumes were added to the systemic arteries and veins respectively.
Maternal cardiovascular parameters were based on pregnancy-related changes as described in literature (part A, Table 1b) . Target values for p tm;a and p tm;v were set to 80 mmHg (Clapp and Capeless, 1997; Geva et al., 1997; Katz et al., 1978) and 5 mmHg (Murray, 2007) respectively. During pregnancy, heart rate HR increases up to a target value of 80 bpm (Clapp and Capeless, 1997; Geva et al., 1997; Katz et al., 1978; Rubler et al., 1977) , while the cardiac output (Abbas et al., 2005; Clapp and Capeless, 1997; Katz et al., 1978; Longo, 1983 ) and blood volume (Abbas et al., 2005; Longo, 1983) both increase by 40%. In our model cardiac output and total blood volume were set to 7 l/min and 7 l, respectively. Ejection fraction was set to a value of 0.67 (Clapp and Capeless, 1997; Geva et al., 1997; Katz et al., 1978) . Intervillous space (IVS) volume was chosen to be 175 ml (Benirschke et al., 2006; Mayhew, 1996; Rainey and Mayhew, 2010) , while the volume of the tissue microcirculation was chosen to be 8% of total maternal blood volume (Guyton and Hall, 2006) . Average left ventricular blood volume follows from q CO , EF and HR and equals 87.5 ml. Like in the fetus, the remainder of the blood volume was distributed over systemic arteries (1/6) and veins (5/6). Parameters p 1 and V max , defining the relation between IVS volume V ivs and transmural blood pressure as described by Eq. (3) 
For C ivs;max we chose a similar value as for the placental villi (2.4 ml/mmHg).
For both fetus and mother target values of blood flows and pressures were used to estimate resistances and compliances. We chose umbilical cord flow to be 25% of q CO , in agreement with literature data that range from 15% to 34% of q CO (Acharya et al., 2005; Kiserud et al., 2006; Link et al., 2007; Parer, 1997; Rudolph, 2009) . The fraction of cardiac output going to the fetal brain was estimated by use of a fractional brain mass of 14% (Cetin et al., 2008; Hofman, 1983) and by the estimation that oxygen metabolism per gram tissue, and thus also blood flow per gram tissue, should be twice as high in brain tissue compared to peripheral tissues. This means that 21% of total cardiac output goes to the brain and 54% to the fetal tissues, which is in accordance with Rudolph (2009) . In the mother about 10% of the cardiac output is directed to the uterine circulation (Flo et al., 2010; Parer, 1997; Vorherr, 1975) , of which 70-90% is directed to the IVS (Parer, 1997; Rosenfeld, 1984; Wang and Zhao, 2010) . Hence we chose 9% of q CO to be directed to the IVS, while 91% is directed to the other maternal tissues.
For the fetal and maternal tissues and fetal brain 95% of the total resistance was assigned to the microcirculation arteries, while 5% was assigned to the microcirculation veins. In the umbilical circulation, the arterial resistance fraction was set to 60%, to obtain a blood pressure of about 20 mmHg in the placental villi (Huikeshoven et al., 1980) . In the uterine circulation this fraction was set to 80%, in order to obtain an IVS pressure of about 60-70 mmHg below mean arterial pressure (Ramsey et al., 1959) . Except for the placental villi and IVS, compliances were estimated assuming that 70% of the volume in the reference state contributes to the unstressed volume. For the cerebral and tissue microcirculation, unstressed volume fraction was set to 90%. The compliance in the placental villi was set to 2.4 ml/ mmHg (Assad et al., 2001; Huikeshoven et al., 1980) . Initial values of V ed and V ee were calculated from target values of q CO , EF and FHR. V min;0 was chosen to be equal to V ee , while V max;0 was set to 0. Finally, E max could be calculated as the slope of a line through the data points (V ee , p tm;a ) and (V max;0 , 0), while E min was calculated as the slope of a line through (V ed , p tm;v ) and ðV min;0 ; 0Þ.
Oxygen distribution
The oxygen diffusion coefficient in the placenta was set to 0.082 ml O 2 =ðs Á mm HgÞ (part A, Table 2) such that in steady state a fetal umbilical arterial oxygen pressure of 18.5 mmHg was obtained (Acharya and Sitras, 2009; Link et al., 2007; Sjöstedt et al., 1960) . Fetal oxygen metabolism was set to be 8 ml O 2 =ðmin Á kgÞ (Acharya and Sitras, 2009; Bonds et al., 1986) and divided over cerebral metabolism (28%) and tissue metabolism (72%). We chose a threshold value of 5 mmHg for cerebral oxygen metabolism ðpO 2;th;cer;f Þ (Jones et al., 1977) and 10 mmHg for the peripheral tissues (pO 2,th,tis,f ), where the latter value corresponds to about 50% of the steady-state oxygen concentration, based on Sá Couto et al. (2002) .
Maternal oxygen consumption was set to 600 ml O 2 /min. The oxygen pressure in the air was set to 160 mmHg, while target maternal arterial oxygen pressure was set to 98 mmHg. Combination of this oxygen pressure difference and total fetomaternal oxygen metabolism yielded a pulmonary oxygen diffusion coefficient of 0.169 ml O 2 =ðs Á mm HgÞ. Since in the current study maternal oxygenation was kept constant, an oxygen metabolism threshold was irrelevant for the maternal model.
Fetal and maternal parameter values defining the relation between cO 2 and pO 2 were chosen as described by Sá Couto et al. (2002) .
Regulation
Cerebral autoregulation: For the cerebral autoregulation the value of γ, indicating how well the cerebral resistance can adapt to variations in arterial oxygen content, was estimated by use of Peeters et al. (1979) and set to a value of 0.5. The cerebral resistance can maximally decrease by 50%, which means that cerebral blood flow can increase with a factor of 2. Finally, the time constant τ Rcera was chosen to be 10 s according to Ursino and Magosso (2000) . 
Baroreceptor parameters were obtained by scaling the relation as described by Ursino and Magosso (2000) to fetal values and normalizing it to a range between À 1 and 1 (part A, Table 3 ). Baroreceptor sensitivity in the fetus is reduced by a factor two as compared to the adult (Dawes et al., 1980) . Parameter values of the Gompertz function were chosen such that the relation between baroreceptor input p tm;a and output r b closely resembled the scaled response of Ursino and Magosso. Parameter values for the chemoreceptor response were chosen such that a reference contraction of 60 s with a pressure amplitude of 70 mmHg would lead to a maximum FHR deceleration of about 3 bpm for uterine flow reduction alone and about 50 bpm for combined uterine flow reduction and umbilical cord compression. The values of the effector gains k and efferent weighting factors w were also chosen to obtain the desired effects in FHR (part A, Table 3 ). For all effectors time delays D and low pass filter time constants τ were obtained from Ursino and
Magosso (2000) (part A, Table 3 ).
Uterine and umbilical blood vessel compressions
In the relation between transmural blood pressure and vessel resistance (part A, Eq. (6)) R 0 was chosen such that Rðp th Þ ¼ R ref , with p th the transmural pressure below which the blood vessel resistance starts to increase and R ref is the reference resistance in steady state. For the uterine vein p 0 and p 1 were chosen such that a contraction with a uterine pressure amplitude of 60 mmHg and a duration of 60 s would result in a 60% blood flow reduction through the uterine artery (Janbu and Nesheim, 1987 ) (part A, Table 1b ). In our model, the uterine arteries are not subjected to increasing uterine pressure. Parameter settings for the umbilical cord resistances were found by simulating the sheep experiments in which initial fetal blood volume changes were measured during umbilical cord compressions with increasing external pressures (Cooper and Greenfield, 1949) . The umbilical vein is totally closed if the external pressure exceeds 40 mmHg, while the umbilical arteries are compressed over a pressure range of 40-90 mmHg (see Table 1 ).
Model simulations
We simulated combined uterine flow reduction and umbilical cord compression in term pregnancy by setting wum ¼ 1 in (2). A reference contraction with a duration (T con ) of 60 s and a pressure amplitude (p con ) of 70 mmHg with respect to the reference pressure (p rest ) of 15 mmHg was used. To illustrate the effect of regulation, simulations with and without central regulation and autoregulation were performed. In addition, the effect of contraction intensity was investigated by changing contraction amplitude from 70 mmHg to 30 and 110 mmHg respectively, or contraction duration from 60 s to 30 and 120 s respectively.
The model was evaluated by use of sheep experiments in which umbilical cord blood flow was temporarily reduced by use of an occluder (Itskovitz et al., 1983) . The sheep experiments were simulated by linearly increasing the external pressure (p um ) on the cord over 5 s to a maximum level, which was maintained for 35 s, and reduced to zero over another 5 s, while keeping p ut at the resting level. In order to obtain umbilical flow reductions of 25%, 50%, 75% or 100%, as presented by Itskovitz et al., maximum external pressure was set to a value of 25, 33, 41, or 90 mmHg, In column B signals represent blood flow through the umbilical vein and arteries (q umv and q uma , respectively); villous blood volume (V villi ); tissue and cerebral oxygen pressure (pO 2;tis and pO 2;cer , respectively); and fetal tissue and cerebral blood flow (q tis and q cer , respectively). Dimensionless signals in column C represent baro-and chemoreceptor outputs (r b and r c , respectively); sympathetic and vagal efferent signals (e s and e v , respectively); relative effector changes z for peripheral vascular resistance (R tisa ), venous unstressed volume ðV ven;0 Þ, and cardiac contractility (E max ), while the 'auto' signal represents the relative change of the autoregulated cerebral resistance (R cera ); and finally relative vagally-and sympathetically-induced heart period changes (z Tv and z Ts , respectively), and the difference between both ðz Tv À z Ts Þ. (Note the change in axes compared to Fig. 3 in part A.) respectively. Umbilical vein and artery resistances, R umv and R uma respectively, were calculated by use of Eq. (6) in part A.
Results
Fig . 1 shows the scenario of combined uterine flow reduction and umbilical cord compression induced by a reference contraction of 60 s with a pressure amplitude of 70 mmHg. Initial values for this scenario are the same as for the scenario of uterine flow reduction alone, as described in part A. In addition, Fig. 1 shows that umbilical blood flow is about 394 ml/min (panel B1) and that villous volume is 83 ml (panel B2). Note that blood pressures described in this section represent transmural blood pressures.
We first consider the simulation without regulation, indicated by the gray lines. During cord compression the external umbilical pressure rises (panel A1) and fetal blood pressure (panel A2) and arterial oxygen pressure (panel A3) decrease. Without regulation, FHR will not be affected (panel A4). If we now look into more detail (column B), we observe that first umbilical venous flow reduces to near zero (panel B1) and that the placental villi are filled via the umbilical arteries (panel B2). Once the umbilical arteries are compressed as well, villous volume remains more or less constant. This blood volume shift from fetus to placenta explains the drop in blood pressure (panel A2) that in turn causes a drop of blood flow through the fetal tissues and brain (panel B4). The reduction of umbilical blood flow decreases arterial, cerebral, and tissue oxygen levels (panel A3 and B3). Initially no difference is observed between the cerebral and tissue oxygen pressures. Later, cerebral oxygen pressure drops deeper than tissue oxygen pressure, which is due to the lower oxygen metabolism threshold value in the brain (part A, Eq. (17) timing of the second dip at 1.6 min is caused by the baroreceptor response. Finally, cerebral autoregulation decreases cerebral vascular resistance (panel C3), thereby increasing cerebral blood flow (panel B4). Together with flow reduction in the tissues caused by the increased peripheral resistance, this results in flow redistribution in favor of the fetal brain. As a consequence the drop in cerebral oxygen pressure is reduced compared to the unregulated case (panel B3).
In Fig. 2 the effect of variation in contraction amplitude and duration is shown. In general an increased or decreased contraction duration has a similar but opposite effect on pressures and FHR, while variation of amplitude has a nonlinear effect. When contraction amplitude is increased to 110 mmHg (column A) only minor changes are seen compared to the reference contraction. When contraction amplitude is reduced to 30 mmHg (column B) umbilical vessels do not become fully blocked, hence less blood is stored in the villi, and thus the drop of arterial blood pressure is reduced. The drop of oxygen pressure is reduced since oxygen supply through venous umbilical flow continues. FHR remains rather constant, because of the reduced baroreceptor and chemoreceptor response. If contraction duration is increased to 120 s (column C) the drop in arterial blood pressure is similar to that during the reference contraction. The increased FHR deceleration is mainly caused by the increased chemoreceptor feedback, in response to the lower oxygen levels. Finally, if contraction duration is decreased to 30 s, less blood is stored in the villi, and the initial arterial pressure drop is reduced. Arterial oxygen pressure drops less deep, due to the shortened duration of umbilical cord compression. FHR drops less deep because of reduced baroreceptor and chemoreceptor feedback. Fig. 3 shows the relative variations in arterial oxygen pressure, blood pressure and FHR during different degrees of umbilical cord block as obtained from sheep data (Itskovitz et al., 1983) and from model simulations. Quantitatively, the simulation results agree well with the experimental data.
Discussion
Parameter estimation. Parameter estimations were described in Section 2.2. The most important choices will be discussed here.
It has been reported that the baroreceptor sensitivity in the fetus is two to eight times lower than that in the adult (Dawes et al., 1980) . In the model, we used a two-fold decrease with respect to settings for the adult, used by Ursino and Magosso (2000) . With this setting, we observed an initial increase of FHR (clinically referred to as 'shoulders') when simulating variable decelerations, which disappeared when further lowering baroreceptor sensitivity.
Clinically, most contractions that affect uterine blood flow alone, lead to reductions in FHR ('late decelerations') that do barely exceed the noise level of the FHR signal in a healthy fetus. In the model, we tuned parameter settings such that simulation of our reference contraction with uterine flow reduction alone yields an FHR deceleration of about 3 bpm. Due to the variable character of the FHR decelerations caused by combined uterine and umbilical flow reduction, there is no typical response for this 'variable deceleration' scenario. We chose a target value of 50 bpm during a reference contraction. Deeper decelerations can be reached if contraction duration or amplitude increases (Fig. 2) .
Since oxygen pressure dropped by 1.5 mmHg in the former scenario, and by 6 mmHg in the latter scenario, chemoreceptor output had to increase steeply over a small arterial oxygen pressure interval. Finally, to obtain the desired results, the effector gains k were multiplied by a factor 6 with respect to Wesseling and Settels (1985) . This adaptation can partly be explained from the fact that in our regulation model the chemoreceptor was added and a larger reduction of FHR was desired. Simulation of other scenarios is needed to test the validity of these parameter settings. However, the clinical or experimental data to validate the model is limited.
Results. Simulation results show that oxygen levels drop more quickly during combined uterine and umbilical flow reduction (Fig. 1) compared to uterine flow reduction alone (part A, Fig. 3 ). This can be explained by the fact that during cord compression the fetus has no access to the IVS oxygen buffer, since oxygen cannot be transported from the placental villi into the fetus. Until the oxygen threshold is reached below which metabolic rate decreases, oxygen content drops linearly in time. Since the oxygen pressures reached are still in the linear range of the saturation curve, oxygen pressure also drops linearly. We observed that FHR increases before onset of the decelerations. This increase is clinically referred to as 'shoulder' (Murray, 2007; Essed et al., 2008; Parer, 1997) . In the clinic these shoulders are often also observed at the end of the deceleration, however this effect was not obtained in the model, presumably due to the dominant sympatheticallyinduced blood pressure increase in our model. During a standard contraction the FHR decreases from baseline to nadir in about 26 s, which is in accordance with the clinical guidelines defining an abrupt decrease in FHR to occur within 30 s (Macones et al., 2008; Robinson, 2008) . Furthermore, FHR reaches baseline levels again within 2 min. This is in accordance with literature (Macones et al., 2008; Robinson, 2008) , although the final part of FHR return seems somewhat slow.
Simulation results of contraction variations (Fig. 2) show that oxygen pressure reduction depends on the duration and amplitude of the contraction, which will both increase during progression of labor. The time delay between onset and nadir of the FHR deceleration increases with increasing contraction amplitude or duration. The wide variation in the shapes of the FHR decelerations corresponds well with the clinical observation that umbilical cord occlusions have a variable character and are therefore called 'variable' decelerations. Clinically, these variations are also caused by variation in the position of the umbilical cord within the uterus. In the model this could be simulated by variation of the weighting factor w um in (2). However, since random variation of this factor would complicate comparison of the results in the various scenarios, we kept this factor constant.
If we compare FHR signals obtained with the current model with the results of our previous model (van der Hout-van der Jagt et al., 2013b), we see that FHR decelerations are now preceded by a shoulder, which was not observed in the previous model. This Fig. 3 . Results from simulations of umbilical cord occlusion, in comparison to experimental results from sheep studies (Itskovitz et al., 1983) . From left to right: relative variations in arterial oxygen pressure ðpO 2;a Þ, transmural arterial blood pressure ðp tm;a Þ, and FHR. N.B.: 'ns' indicates that the relative flow reduction does not result in a significant variation with respect to the steady-state value.
shoulder can partly be attributed to increased filling of the villi, due to the fact that the umbilical arteries remain patent, and partly to the stronger baroreceptor response in the current model. The model generates estimates of many physiological signals, while in clinical practice only FHR can be measured continuously. To gain more insight into the complex pathway from uterine contractions to FHR changes, we also show signals that cannot be measured in the clinic. Since these intermediate signals cannot be compared to human data, we used sheep data on oxygen pressure and blood pressure to evaluate the model, noting that quantitative comparison with sheep data is difficult due to the differences between the ovine and human fetus. For example, in fetal lambs about 40-45% of the cardiac output is directed to the umbilical circulation (Jensen et al., 1991; Parer, 1997; Rudolph, 2009) , while in the human fetus this is only 25%. Despite the differences between human and sheep fetuses, for the simulations of umbilical cord blocking, results were quantitatively in accordance with sheep experiments (Fig. 3) .
Limitations. Although we reduced the number of model parameters to be estimated, it is still difficult to arrive at a unique set of model parameter settings from the limited experimental data presented in literature. Consequently, there may be different combinations of parameter choices which will lead to similar results. In future a sensitivity analysis should be performed in order to investigate which parameters dominate model response and should be determined very precisely and for which parameters a more general value can be used.
The model lacks the ability to describe FHR variability, which is an important indicator of fetal distress in clinical practice. Addition of this variability would further improve applicability of the model for training purposes and clinical diagnosis and decision making.
The current model is intended to describe CTG signals during short-term hypoxia and to provide additional information on fetal oxygen status. To be able to describe the effects caused by stronger and longer contractions, humoral feedback has to be added to the model (Murray, 2007) , and the shift of the fetal oxygen dissociation curve due to the changes in pH (Bohr effect) should be taken into account. Furthermore, cardiac metabolism and the effect of myocard hypoxia on FHR might be included in the model. In the hemodynamic model of the fetus, the fetal heart is represented by a combined ventricle. To describe improved oxygen supply to the brain due to preferential blood flows, the combined ventricle might be replaced by a separate left and right ventricle.
Conclusion. With the improved model we were able to generate realistic variable decelerations for the scenario of combined uterine and umbilical flow reduction. Parameter estimation of the simplified model remains difficult due to the limited availability of clinical and experimental data.
